SHRG: Sharing Services Global Corporation Stock

SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries

Valuation
Market Cap ($M) 0.65
Enterprise Value ($M) 2.62
Book Value ($M) -4.21
Book Value / Share -13.61
Price / Book -0.15
NCAV ($M) -6.25
NCAV / Share -20.19
Price / NCAV -0.10

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.55
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.31
Current Ratio 0.45

Balance Sheet (mrq) ($M)
Current Assets 4.22
Assets 6.26
Liabilities 10.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 ☐ TRANSITION REPORT PURSUAN
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-07-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended MARCH 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION

(click for more detail)

Similar Companies
PURA – Puration, Inc. RIGH – Bud Genius, Inc.
RSSFF – Affinor Growers Inc. SHTDF – Sinopharm Group Co. Ltd.
STEK – Stemtech Corporation


Financial data and stock pages provided by
Fintel.io